ImmunityBio, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending December 31, 2024: -103.88%

ImmunityBio, Inc. Return on Assets (ROA) is -103.88% for the Trailing 12 Months (TTM) ending December 31, 2024, a -33.96% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.
  • ImmunityBio, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending December 31, 2023 was -157.31%, a 34.27% change year over year.
  • ImmunityBio, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending December 31, 2022 was -117.16%, a -3.80% change year over year.
  • ImmunityBio, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending December 31, 2021 was -121.78%.
Key Data
Date Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share Dividend Per Share